Prot# TFP008: A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind, 3-Arm Study to Evaluate the Safety & Efficacy of Tifacogin(Recombinant Tissue Factor Pathway Inhibitor) Administration in Subjects w/Severe Community-Acquired Pneumonia

Project: Research project

Project Details

StatusFinished
Effective start/end date4/1/049/1/11

Funding

  • PRA Health Sciences (TFP008 // TFP008)
  • Chiron Corporation (TFP008 // TFP008)